BioRem Inc.
BRM.V · TSXV
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CA$37,419 | CA$25,165 | CA$28,863 | CA$24,478 |
| % Growth | 48.7% | -12.8% | 17.9% | – |
| Cost of Goods Sold | CA$27,363 | CA$18,143 | CA$20,101 | CA$18,242 |
| Gross Profit | CA$10,056 | CA$7,022 | CA$8,762 | CA$6,236 |
| % Margin | 26.9% | 27.9% | 30.4% | 25.5% |
| R&D Expenses | CA$44 | CA$30 | CA$97 | CA$14 |
| G&A Expenses | CA$2,124 | CA$1,627 | CA$3,203 | CA$1,816 |
| SG&A Expenses | CA$5,618 | CA$3,905 | CA$5,786 | CA$3,913 |
| Sales & Mktg Exp. | CA$3,494 | CA$2,279 | CA$2,583 | CA$2,098 |
| Other Operating Expenses | CA$50 | CA$24 | CA$0 | CA$0 |
| Operating Expenses | CA$5,712 | CA$3,959 | CA$5,883 | CA$3,903 |
| Operating Income | CA$4,344 | CA$3,063 | CA$2,641 | CA$2,070 |
| % Margin | 11.6% | 12.2% | 9.1% | 8.5% |
| Other Income/Exp. Net | -CA$195 | -CA$273 | -CA$257 | -CA$36 |
| Pre-Tax Income | CA$4,148 | CA$2,789 | CA$2,383 | CA$2,034 |
| Tax Expense | CA$1,105 | CA$610 | CA$770 | CA$737 |
| Net Income | CA$3,044 | CA$2,179 | CA$1,613 | CA$1,297 |
| % Margin | 8.1% | 8.7% | 5.6% | 5.3% |
| EPS | 0.19 | 0.14 | 0.1 | 0.036 |
| % Growth | 35.7% | 40% | 177% | – |
| EPS Diluted | 0.16 | 0.13 | 0.092 | 0.035 |
| Weighted Avg Shares Out | 15,765 | 15,672 | 15,485 | 35,922 |
| Weighted Avg Shares Out Dil | 18,714 | 17,107 | 17,555 | 37,411 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$195 | CA$273 | CA$257 | CA$36 |
| Depreciation & Amortization | CA$473 | CA$383 | CA$351 | CA$344 |
| EBITDA | CA$4,817 | CA$3,445 | CA$2,991 | CA$2,677 |
| % Margin | 12.9% | 13.7% | 10.4% | 10.9% |